NEXGEL, Inc. (NXGL)

USD 4.23

(-10.19%)

Revenue Summary of NEXGEL, Inc.

  • NEXGEL, Inc.'s latest annual revenue in 2023 was 4.08 Million USD , up 99.66% from previous year.
  • NEXGEL, Inc.'s latest quarterly revenue in 2024 Q2 was 1.44 Million USD , up 13.74% from previous quarter.
  • NEXGEL, Inc. reported a annual revenue of 2.04 Million USD in annual revenue 2022, up 32.04% from previous year.
  • NEXGEL, Inc. reported a annual revenue of 1.55 Million USD in annual revenue 2021, up 130.12% from previous year.
  • NEXGEL, Inc. reported a quarterly revenue of 1.44 Million USD for 2024 Q2, up 13.74% from previous quarter.
  • NEXGEL, Inc. reported a quarterly revenue of 620 Thousand USD for 2023 Q1, up 18.32% from previous quarter.

Annual Revenue Chart of NEXGEL, Inc. (2023 - 2016)

Historical Annual Revenue of NEXGEL, Inc. (2023 - 2016)

Year Revenue Revenue Growth
2023 4.08 Million USD 99.66%
2022 2.04 Million USD 32.04%
2021 1.55 Million USD 130.12%
2020 674 Thousand USD -6.0%
2019 717 Thousand USD -67.6%
2018 2.21 Million USD 11.09%
2017 1.99 Million USD -7.43%
2016 2.15 Million USD 0.0%

Peer Revenue Comparison of NEXGEL, Inc.

Name Revenue Revenue Difference
Akoya Biosciences, Inc. 96.63 Million USD 95.769%
AngioDynamics, Inc. 303.91 Million USD 98.655%
AtriCure, Inc. 399.24 Million USD 98.976%
Avinger, Inc. 7.65 Million USD 46.563%
Azenta, Inc. 665.07 Million USD 99.385%
BioLife Solutions, Inc. 143.27 Million USD 97.146%
The Cooper Companies, Inc. 3.59 Billion USD 99.886%
Daxor Corporation 1.28 Million USD -219.325%
Ekso Bionics Holdings, Inc. 18.27 Million USD 77.63%
Femasys Inc. 1.07 Million USD -281.447%
GlucoTrack, Inc. - USD -Infinity%
Harvard Bioscience, Inc. 112.25 Million USD 96.357%
Hologic, Inc. 4.03 Billion USD 99.899%
ICU Medical, Inc. 2.25 Billion USD 99.819%
Intuitive Surgical, Inc. 7.12 Billion USD 99.943%
KORU Medical Systems, Inc. 28.51 Million USD 85.662%
LeMaitre Vascular, Inc. 193.48 Million USD 97.887%
Innovative Eyewear, Inc. 1.15 Million USD -254.8%
Innovative Eyewear, Inc. 1.15 Million USD -254.8%
Masimo Corporation 2.04 Billion USD 99.8%
Microbot Medical Inc. - USD -Infinity%
Meihua International Medical Technologies Co., Ltd. 97.09 Million USD 95.789%
Merit Medical Systems, Inc. 1.25 Billion USD 99.675%
Nephros, Inc. 14.23 Million USD 71.281%
NovoCure Limited 509.33 Million USD 99.197%
NEXGEL, Inc. 4.08 Million USD 0.0%
Singular Genomics Systems, Inc. 2.91 Million USD -40.467%
OraSure Technologies, Inc. 405.47 Million USD 98.992%
Pro-Dex, Inc. 53.84 Million USD 92.406%
Pulse Biosciences, Inc. - USD -Infinity%
Predictive Oncology Inc. 1.78 Million USD -129.707%
Precision Optics Corporation, Inc. 19.1 Million USD 78.596%
QuidelOrtho Corporation 2.99 Billion USD 99.864%
Repligen Corporation 638.76 Million USD 99.36%
Sanara MedTech Inc. 64.98 Million USD 93.708%
STAAR Surgical Company 322.41 Million USD 98.732%
Sharps Technology, Inc. - USD -Infinity%
Utah Medical Products, Inc. 50.22 Million USD 91.858%
DENTSPLY SIRONA Inc. 3.96 Billion USD 99.897%
Jin Medical International Ltd. 19.82 Million USD 79.371%